Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan
Print
Written by
ClinicalTrials.gov
Category:
Bone diseases
Published: 19 July 2011
Condition
: Osteoporosis, Postmenopausal
Intervention
: Drug: E2 transdermal (Julina, BAY86-5435)
Sponsor
: Bayer
Recruiting
- verified August 2011
Details
Last Updated: 19 July 2011